Anuh Pharma Acquires Vanquest Pharma Manufacturing Facility for ₹72.90 Crore
Anuh Pharma Ltd · Others (Uncategorized) · 17 Oct 2026, 12:24 am
Anuh Pharma Acquires Vanquest Pharma Manufacturing Facility for ₹72.90 Crore Anuh Pharma signed an Asset Transfer Agreement on 16th Oct'26 to acquire the API and intermediates manufacturing facility of Vanquest Pharma at Tarapur, Maharashtra, for a cash consideration of ₹72.90 crore (excluding taxes). The transaction encompasses land, buildings, plant, and machinery, and is expected to boost Anuh Pharma's overall production capacity by 525 MTPA. The non-related-party acquisition aims to strengthen the company’s manufacturing capabilities and market footprint in APIs and intermediates without any equity dilution or board appointments.
Original exchange filing (PDF)
More announcements from Anuh Pharma Ltd
- Capacity Addition by inauguration of the F-10/1, M.I.D.C., Tarapur, Boisar, District Palghar - 401506, Maharashtra, India. · 16 Nov 2026
- This is to inform that the Company has inaugurated its new manufacturing facility situated at F-10/1, M.I.D.C., Tarapur, Boisar, District Palghar - 401506, Maharashtra, India. · 16 Nov 2026
- Investor Presentation for Q2 and H1 FY 2026-27 · 06 Nov 2026
- Request received for withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group" to "Public Category". · 30 Oct 2026
- Unaudited Financial Results for the Quarter and half year ended 30th September, 2026. · 30 Oct 2026
- Anuh Pharma Limited has informed the Exchange regarding 'Financial Results'. · 30 Oct 2026
- To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter and half year ended 30th September, 2026 and Request received for withdrawal .... · 30 Oct 2026
- Anuh Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
